Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal CarcinomaFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorderRecruitingPhase 42026-07-14NCT07028125

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Centre Francois Baclesse35

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Antoine LacassagneNiceFrance60
Centre d'oncologie St YvesVannesFrance1
Centre François BaclesseCaenFrance39
Centre Hospitalier d'AnnecyAnnecyFrance1
Centre Hospitalier de BayeuxBayeuxFrance1
Centre Hospitalier de LorientLorientFrance1
Centre Hospitalier de ToursToursFrance1
Centre Léon BérardLyonFrance71
CH Boulogne sur merBoulogne-sur-MerFrance3
CHUSaint-EtienneFrance3
CHU MontpellierMontpellierFrance56
CHU PoitiersPoitiersFrance70
GHPSO CreilCreilFrance2
Ghr Mulhouse Sud AlsaceMulhouseFrance3
Hôpital FochSuresnesFrance27
Institut Andrée DutreixCoudekerque-BrancheFrance2
Institut de cancérologie de BourgogneDijonFrance6
Institut Sainte CatherineAvignonFrance16
Polyclinique du Parc ElsanCaenFrance1